loadpatents
name:-0.069295167922974
name:-0.05177903175354
name:-0.0076420307159424
Brooks; Peter C. Patent Filings

Brooks; Peter C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brooks; Peter C..The latest application filed is for "enhancing the therapeutic activity of immune checkpoint inhibitor".

Company Profile
5.27.31
  • Brooks; Peter C. - Harpswell ME
  • Brooks; Peter C. - Scarborough ME
  • Brooks; Peter C. - Carmel NY
  • Brooks; Peter C. - Hollywood CA
  • Brooks; Peter C. - Los Angeles CA
  • Brooks; Peter C. - West Harrison NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Enhancing The Therapeutic Activity Of Immune Checkpoint Inhibitor
App 20210155696 - Brooks; Peter C. ;   et al.
2021-05-27
Enhancing The Therapeutic Activity Of An Immune Checkpoint Inhibitor
App 20210100901 - Brooks; Peter C. ;   et al.
2021-04-08
Enhancing the therapeutic activity of immune checkpoint inhibitor
Grant 10,906,977 - Brooks , et al. February 2, 2
2021-02-02
Enhancing the therapeutic activity of an immune checkpoint inhibitor
Grant 10,881,732 - Brooks , et al. January 5, 2
2021-01-05
Compositions and methods for treating inflammation and fibrosis
Grant 9,890,208 - Brooks , et al. February 13, 2
2018-02-13
Enhancing The Therapeutic Activity Of Immune Checkpoint Inhibitor
App 20170240638 - Brooks; Peter C. ;   et al.
2017-08-24
Enhancing The Therapeutic Activity Of An Immune Checkpoint Inhibitor
App 20170065716 - Brooks; Peter C. ;   et al.
2017-03-09
Treatment of cancer using benzoic acid derivatives
Grant 9,018,259 - Brooks , et al. April 28, 2
2015-04-28
Compositions And Methods For Treating Inflammation And Fibrosis
App 20150010552 - Brooks; Peter C. ;   et al.
2015-01-08
Treatment of cancer using the sodium salt of a benzoic acid derivative
Grant 8,710,099 - Brooks , et al. April 29, 2
2014-04-29
Treatment Of Cancer Using Benzoic Acid Derivatives
App 20120329861 - Brooks; Peter C. ;   et al.
2012-12-27
Compositions And Methods For Treating Inflammation And Fibrosis
App 20120237504 - Brooks; Peter C. ;   et al.
2012-09-20
Treatment Of Cancer Using The Sodium Salt Of A Benzoic Acid Derivative
App 20120203051 - Brooks; Peter C. ;   et al.
2012-08-09
Treatment of cancer using benzoic acid derivatives
Grant 8,198,328 - Brooks , et al. June 12, 2
2012-06-12
CLK-peptide and SLK-peptide
Grant 8,133,471 - Brooks , et al. March 13, 2
2012-03-13
Antagonists and methods for inhibiting angiogenesis
Grant 8,025,883 - Brooks , et al. September 27, 2
2011-09-27
Inhibition Of Melanogenesis And Melanoma Metastasis With P-amino Benzoic Acid (paba)
App 20100323002 - Brooks; Peter C. ;   et al.
2010-12-23
Clk-peptide And Slk-peptide
App 20100226852 - Brooks; Peter C. ;   et al.
2010-09-09
Methods for treating non-melanoma cancers with PABA
Grant 7,705,049 - Brooks , et al. April 27, 2
2010-04-27
Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA)
Grant 7,691,905 - Brooks , et al. April 6, 2
2010-04-06
CLK-peptide and SLK-peptide
Grant 7,662,783 - Brooks , et al. February 16, 2
2010-02-16
CLK-peptide and SLK-peptide
Grant 7,601,694 - Brooks , et al. October 13, 2
2009-10-13
Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies
Grant 7,595,051 - Brooks , et al. September 29, 2
2009-09-29
Antagonists specific for denatured collagen and methods of using same
Grant 7,588,760 - Brooks , et al. September 15, 2
2009-09-15
STQ Peptides
App 20090226369 - Brooks; Peter C. ;   et al.
2009-09-10
Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and .beta.1 integrins
Grant 7,566,449 - Brooks , et al. July 28, 2
2009-07-28
Antagonists Specific For Denatured Collagen And Methods Of Using Same
App 20090028867 - Brooks; Peter C. ;   et al.
2009-01-29
Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies
Grant 7,482,007 - Brooks , et al. January 27, 2
2009-01-27
STQ peptides
Grant 7,387,998 - Brooks , et al. June 17, 2
2008-06-17
Methods of treating arthritis and diabetic retinopathy with .alpha..sub.v.beta..sub.3-specific antibodies
Grant 7,354,586 - Brooks , et al. April 8, 2
2008-04-08
Antagonists specific for denatured collagen and methods of using same
Grant 7,345,151 - Brooks , et al. March 18, 2
2008-03-18
Methods of treating psoriasis with .alpha..sub.v.beta..sub.3-specific antibodies
Grant 7,329,406 - Brooks , et al. February 12, 2
2008-02-12
CLK-peptide and SLK-peptide
App 20070259817 - Brooks; Peter C. ;   et al.
2007-11-08
Combination therapies for inhibiting integrin-extracellular matrix interactions
App 20070048325 - Van Epps; Dennis ;   et al.
2007-03-01
Methods for inhibition of angiogenesis
App 20060270710 - Brooks; Peter C. ;   et al.
2006-11-30
Methods of inhibiting angiogenesis-dependent conditions mediated by cryptic epitopes of extracellular matrix components
App 20060240002 - Brooks; Peter C. ;   et al.
2006-10-26
Method and composition for angiogenesis inhibition
Grant 7,122,635 - Brooks , et al. October 17, 2
2006-10-17
Inhibition of angiogenesis and tumor development by IGFBP-4
App 20060216237 - Brooks; Peter C. ;   et al.
2006-09-28
Methods of inhibiting alphavBeta3-mediated angiogenesis and tumor development
App 20060216236 - Brooks; Peter C. ;   et al.
2006-09-28
Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and .beta.1 integrins
Grant 7,101,975 - Brooks , et al. September 5, 2
2006-09-05
Methods and compositions useful for inhibition of .alpha..sub.v.beta..sub.5mediated angiogenesis
Grant 7,053,041 - Brooks , et al. May 30, 2
2006-05-30
Antagonists and methods for inhibiting angiogenesis
App 20060088540 - Brooks; Peter C. ;   et al.
2006-04-27
Antagonists specific for denatured collagen and methods of using same
App 20060067932 - Brooks; Peter C. ;   et al.
2006-03-30
Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2
Grant 7,019,108 - Brooks , et al. March 28, 2
2006-03-28
Novel method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta1 integrins
App 20060062777 - Brooks; Peter C. ;   et al.
2006-03-23
Method and composition for angiogenesis inhibition
App 20050281821 - Pernasetti, Flavia ;   et al.
2005-12-22
Methods for treating non-melanoma cancers with PABA
App 20050220705 - Brooks, Peter C. ;   et al.
2005-10-06
Treatment of cancer using benzoic acid derivatives
App 20050209334 - Brooks, Peter C. ;   et al.
2005-09-22
Methods and compositions useful for inhibition of angiogenesis
App 20050002936 - Brooks, Peter C. ;   et al.
2005-01-06
CLK-peptide and SLK-peptide
App 20040242490 - Brooks, Peter C. ;   et al.
2004-12-02
STQ peptides
App 20040224896 - Brooks, Peter C. ;   et al.
2004-11-11
Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA)
App 20040167222 - Brooks, Peter C. ;   et al.
2004-08-26
Methods for inhibition of angiogenesis
App 20040063790 - Brooks, Peter C. ;   et al.
2004-04-01
Method And Composition For Angiogenesis Inhibition
App 20030113331 - BROOKS, PETER C. ;   et al.
2003-06-19
Methods and compositions useful for inhibition of angiogenesis
Grant 6,500,924 - Brooks , et al. December 31, 2
2002-12-31
Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2
App 20020182215 - Brooks, Peter C. ;   et al.
2002-12-05
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed